Treace Medical Concepts
TMCI
TMCI
135 hedge funds and large institutions have $278M invested in Treace Medical Concepts in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+2
Holders Change %
+1.5%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
43
Reduced
45
Closed
23
Calls
$1.21M
Puts
$145K
Net Calls
+$1.07M
Net Calls Change
+$1.25M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$7.21M |
| 2 |
JPMorgan Chase & Co
New York
|
$14.7M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
$21.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$1.95M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$1.41M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$15.9M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$9.59M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
$0 |
| 4 |
BlackRock
New York
|
$28.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
$661K |
